Aging is a complex, universal condition leading to
the functional decline of all cells and organisms, and to major national and global
public health problems.
Although aging is the major risk factor for developing most adult-onset diseases, systematic investigations into
the fundamental physiology, biology and genetics of aging are only just beginning.
IN THE MEDIA
U.S. News & World Report interviews Nir Barzilai, M.D., about his longevity genes research with healthy centenarians, or so-called SuperAgers. Dr. Barzilai notes that many of his vital study participants smoke, drink and are overweight, but with the right genes, their bodies are protected. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
(Friday, May 11, 2012)The Daily News interviews Nir Barzilai, M.D., about the rise in senior citizens staying in the workforce into their 80s and 90s and his research into the longevity genes of SuperAgers, a group of healthy and active centenarians. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
(Monday, April 30, 2012)The Associated Press interviews Nir Barzilai, M.D., about falsified University of Connecticut research on resveratrol, the red wine ingredient thought to improve health. Dr. Barzilai notes that the allegations will have no impact on resveratrol research because encouraging results have emerged from numerous labs around the world, including Einstein’s. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research. (Friday, January 13, 2012)
CBS’ The Early Show interviews Nir Barzilai, M.D., about his genetics research into exceptional longevity in a segment featuring Longevity Genes Project study participant and world’s oldest stock broker Irving Kahn (age 105). Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research. (Wednesday, December 14, 2011)
The Forward has named Nir Barzilai, M.D., to “The Forward 50,” the magazine’s annual list of those who have made a significant impact on the Jewish story in the past year. Dr. Barzilai, who was recently featured in a cover story in New York magazine, was highlighted in The Forward for his longevity research at Einstein and leadership role in the centenarian consortium for the $10 million Archon Genomics X Prize competition. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research. (Thursday, November 17, 2011)